ADCT vs COIN · rev $40.1M vs P/E 64, rev $2.63B
ADC Therapeutics SA (ADCT) versus Coinbase Global Inc (COIN) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
Latest reported COIN revenue for 2026-06-30 was $2.63B. Net income was -$753.6M. Revenue was up 86.3% from 2026-03-31 to 2026-06-30. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
ADCT currently screens at market cap $141.2M. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Not investment advice. Open the ADCT and COIN stock pages for the full models.
Not investment advice.